10/22/2014 - 2:16pm

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

10/22/2014 - 1:50pm

The Food and Drug Administration last week announced plans to survey pharmacists and patients about their experiences resulting from changes in generic drug pill appearance.

10/22/2014 - 11:20am

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

10/22/2014 - 8:47am

Adult millennials ages 18 years to 32 years worry about their health and access to health care as much as their baby boomer elders.

10/22/2014 - 8:15am

Amneal Pharmaceuticals on Tuesday announced that the company has won the global “Company of the Year” Award from Generics bulletin.

10/21/2014 - 11:35am

Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis.

10/21/2014 - 10:02am

Have an idea for a new health app? The Health Lab recently announced that it is accepting applications for a dedicated and concentrated mentorship program.

10/21/2014 - 8:49am

A team of scientists, led by researchers at the Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-14 influenza season.

 

10/21/2014 - 7:47am

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.